SciSparc (SPRC) Interest Coverage Ratio (2016 - 2022)
SciSparc (SPRC) posted Interest Coverage Ratio of 0.82 for Q4 2022, up 139.89% sequentially from 2.06 in Q3 2022.
SciSparc (SPRC) Interest Coverage Ratio (2016 - 2022) Analysis & Trends
SciSparc has reported Interest Coverage Ratio for 4 years, with the latest figure at 0.82 in Q4 2022.
- Quarterly Interest Coverage Ratio changed N/A year-over-year to 0.82 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 5.02 (changed N/A YoY) and the FY2025 annual result came in at 1.02, down 112.52% from the prior year.
- Interest Coverage Ratio grew to 0.82 in Q4 2022 per SPRC's latest filing, from 2.06 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1067.0 in Q1 2018 and troughed at 260.27 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 1.42 |
| 10 | SciSparc | 807,202.50 | 807,202.50 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.82 |
| Sep 30, 2022 | -2.06 |
| Dec 31, 2018 | -260.27 |
| Sep 30, 2018 | 2.96 |
| Jun 30, 2018 | -3.91 |
| Mar 31, 2018 | 1,067.00 |
| Dec 31, 2017 | -69.82 |
| Sep 30, 2017 | -13.41 |
| Dec 31, 2016 | -118.77 |
| Sep 30, 2016 | -30.94 |
| Jun 30, 2016 | -110.40 |